Home › Companies › TRANSMEDICS GROUP INC. › 2024-2025

TRANSMEDICS GROUP INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and TRANSMEDICS GROUP INC.’s Form 8-K, filed May 23, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

10Ballot items
343Asset managers
3,314Fund votes
May 22, 2025Meeting date

Results at a glance

Meeting of May 22, 2025: 10 items on TRANSMEDICS GROUP INC.’s Form 8-K, filed May 23, 2025: 8 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TRANSMEDICS GROUP INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by TRANSMEDICS GROUP INC.

These tallies are TRANSMEDICS GROUP INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 23, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TRANSMEDICS GROUP INC. — official shareholder meeting results, meeting held May 22, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Waleed Hassanein, M.D	21,530,830	124,816	38,595	--	4,939,164	99.4%	Elected	—
Elect Director: James R. Tobin	21,154,414	491,441	48,386	--	4,939,164	98%	Elected	—
Elect Director: Edward M. Basile	19,518,021	2,128,247	47,973	--	4,939,164	90%	Elected	—
Elect Director: Thomas J. Gunderson	21,367,800	277,962	48,479	--	4,939,164	99%	Elected	—
Elect Director: Edwin M. Kania, Jr.	19,583,104	2,062,278	48,859	--	4,939,164	90%	Elected	—
Elect Director: Stephanie Lovell	21,338,519	305,597	50,125	--	4,939,164	99%	Elected	—
Elect Director: Merilee Raines	21,421,630	224,815	47,796	--	4,939,164	99%	Elected	—
Elect Director: David Weill, M.D.	21,250,720	395,207	48,314	--	4,939,164	98%	Elected	—
2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes	20,883,760	755,962	54,519	--	4,939,164	97%	Approved	—
3. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2025, based on the following votes	24,433,217	2,147,182	53,006	--	--	92%	Approved	—

Source: TRANSMEDICS GROUP INC., Form 8-K, filed with the SEC on May 23, 2025 — read the filing on EDGAR.

How asset managers voted at the TRANSMEDICS GROUP INC. 2024-2025 meeting

Each item below shows how the 343 asset managers that disclosed a TRANSMEDICS GROUP INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Waleed Hassanein, M.D

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 21,530,830AGAINST: 124,816

Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Waleed H. Hassanein, M.D.

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Waleed Hassanein, M.D”): 21,530,830 for, 124,816 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 12,646,757 for, 2 against, 4,796 abstained.

FOR

FOR: 12,646,757AGAINST: 2ABSTAIN: 4,796

Largest asset managers voting on “Election of Directors: Waleed H. Hassanein, M.D.” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Vote
Vanguard	3,478,096	For
Fidelity	2,943,949	For
BlackRock	1,642,236	For
Delaware/Macquarie	768,488	For
MUTUAL FUND SERIES TRUST	674,716	For
WASATCH FUNDS TRUST	333,215	For
Royce	295,460	For
Charles Schwab	270,583	For
JPMorgan	184,147	For
Bridge Builder Trust	149,479	For
Invesco	148,079	For
Brown Capital Management Mutual Funds	145,287	For
Principal	137,752	For
FINANCIAL INVESTORS TRUST	132,720	For
Hartford	110,589	For
DRIEHAUS MUTUAL FUNDS	104,954	For
Columbia Threadneedle	90,934	For
Waddell & Reed	83,243	For
Lincoln Financial	81,922	For
Equitable	72,895	For
QUANTITATIVE MASTER SERIES LLC	55,397	For
Jackson National	41,690	For
Janus Detroit Street Trust	37,688	For
RBB FUND, INC.	36,790	For
Empower	31,807	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

2. Elect Director: James R. Tobin

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 21,154,414AGAINST: 491,441

Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: James R. Tobin

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: James R. Tobin”): 21,154,414 for, 491,441 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 12,628,932 for, 17,827 against, 4,796 abstained.

FOR

FOR: 12,628,932AGAINST: 17,827ABSTAIN: 4,796

Largest asset managers voting on “Election of Directors: James R. Tobin” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,476,725	1,371	For
Fidelity	2,943,949	0	For
BlackRock	1,642,236	0	For
Delaware/Macquarie	768,488	0	For
MUTUAL FUND SERIES TRUST	674,716	0	For
WASATCH FUNDS TRUST	333,215	0	For
Royce	295,460	0	For
Charles Schwab	270,583	0	For
JPMorgan	184,147	0	For
Bridge Builder Trust	143,434	6,045	For
Invesco	148,079	0	For
Brown Capital Management Mutual Funds	145,287	0	For
Principal	137,752	0	For
FINANCIAL INVESTORS TRUST	132,720	0	For
Hartford	110,589	0	For
DRIEHAUS MUTUAL FUNDS	104,954	0	For
Columbia Threadneedle	90,934	0	For
Waddell & Reed	83,243	0	For
Lincoln Financial	81,922	0	For
Equitable	72,895	0	For
QUANTITATIVE MASTER SERIES LLC	55,397	0	For
Jackson National	41,690	0	For
Janus Detroit Street Trust	37,688	0	For
RBB FUND, INC.	36,790	0	For
Empower	31,807	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

3. Elect Director: Edward M. Basile

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%

FOR: 19,518,021AGAINST: 2,128,247

Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Edward M. Basile

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Edward M. Basile”): 19,518,021 for, 2,128,247 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 11,620,691 for, 1,026,068 against, 4,796 abstained.

FOR

FOR: 11,620,691AGAINST: 1,026,068ABSTAIN: 4,796

Largest asset managers voting on “Election of Directors: Edward M. Basile” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,478,092	4	For
Fidelity	2,943,949	0	For
BlackRock	1,642,236	0	For
Delaware/Macquarie	0	768,488	Against
MUTUAL FUND SERIES TRUST	674,716	0	For
WASATCH FUNDS TRUST	333,215	0	For
Royce	295,460	0	For
Charles Schwab	270,583	0	For
JPMorgan	184,147	0	For
Bridge Builder Trust	143,434	6,045	For
Invesco	148,079	0	For
Brown Capital Management Mutual Funds	145,287	0	For
Principal	137,752	0	For
FINANCIAL INVESTORS TRUST	132,720	0	For
Hartford	110,589	0	For
DRIEHAUS MUTUAL FUNDS	104,954	0	For
Columbia Threadneedle	0	90,934	Against
Waddell & Reed	0	83,243	Against
Lincoln Financial	45,687	36,235	Mixed
Equitable	72,895	0	For
QUANTITATIVE MASTER SERIES LLC	55,397	0	For
Jackson National	41,690	0	For
Janus Detroit Street Trust	37,688	0	For
RBB FUND, INC.	36,790	0	For
Empower	31,807	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

4. Elect Director: Thomas J. Gunderson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 21,367,800AGAINST: 277,962

Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Thomas J. Gunderson

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Thomas J. Gunderson”): 21,367,800 for, 277,962 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 12,646,602 for, 157 against, 4,796 abstained.

FOR

FOR: 12,646,602AGAINST: 157ABSTAIN: 4,796

Largest asset managers voting on “Election of Directors: Thomas J. Gunderson” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,478,095	1	For
Fidelity	2,943,949	0	For
BlackRock	1,642,236	0	For
Delaware/Macquarie	768,488	0	For
MUTUAL FUND SERIES TRUST	674,716	0	For
WASATCH FUNDS TRUST	333,215	0	For
Royce	295,460	0	For
Charles Schwab	270,583	0	For
JPMorgan	184,147	0	For
Bridge Builder Trust	149,479	0	For
Invesco	148,079	0	For
Brown Capital Management Mutual Funds	145,287	0	For
Principal	137,752	0	For
FINANCIAL INVESTORS TRUST	132,720	0	For
Hartford	110,589	0	For
DRIEHAUS MUTUAL FUNDS	104,954	0	For
Columbia Threadneedle	90,934	0	For
Waddell & Reed	83,243	0	For
Lincoln Financial	81,922	0	For
Equitable	72,895	0	For
QUANTITATIVE MASTER SERIES LLC	55,397	0	For
Jackson National	41,690	0	For
Janus Detroit Street Trust	37,688	0	For
RBB FUND, INC.	36,790	0	For
Empower	31,807	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

5. Elect Director: Edwin M. Kania, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%

FOR: 19,583,104AGAINST: 2,062,278

Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Edwin M. Kania, Jr.

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Edwin M. Kania, Jr.”): 19,583,104 for, 2,062,278 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 12,637,059 for, 9,700 against, 4,796 abstained.

FOR

FOR: 12,637,059AGAINST: 9,700ABSTAIN: 4,796

Largest asset managers voting on “Election of Directors: Edwin M. Kania, Jr.” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,478,092	4	For
Fidelity	2,943,949	0	For
BlackRock	1,642,236	0	For
Delaware/Macquarie	768,488	0	For
MUTUAL FUND SERIES TRUST	674,716	0	For
WASATCH FUNDS TRUST	333,215	0	For
Royce	295,460	0	For
Charles Schwab	270,583	0	For
JPMorgan	184,147	0	For
Bridge Builder Trust	143,434	6,045	For
Invesco	148,079	0	For
Brown Capital Management Mutual Funds	145,287	0	For
Principal	137,752	0	For
FINANCIAL INVESTORS TRUST	132,720	0	For
Hartford	110,589	0	For
DRIEHAUS MUTUAL FUNDS	104,954	0	For
Columbia Threadneedle	90,934	0	For
Waddell & Reed	83,243	0	For
Lincoln Financial	81,922	0	For
Equitable	72,895	0	For
QUANTITATIVE MASTER SERIES LLC	55,397	0	For
Jackson National	41,690	0	For
Janus Detroit Street Trust	37,688	0	For
RBB FUND, INC.	36,790	0	For
Empower	31,807	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

6. Elect Director: Stephanie Lovell

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 21,338,519AGAINST: 305,597

Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Stephanie Lovell

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Stephanie Lovell”): 21,338,519 for, 305,597 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 12,637,089 for, 9,670 against, 4,796 abstained.

FOR

FOR: 12,637,089AGAINST: 9,670ABSTAIN: 4,796

Largest asset managers voting on “Election of Directors: Stephanie Lovell” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,478,095	1	For
Fidelity	2,943,949	0	For
BlackRock	1,642,236	0	For
Delaware/Macquarie	768,488	0	For
MUTUAL FUND SERIES TRUST	674,716	0	For
WASATCH FUNDS TRUST	333,215	0	For
Royce	295,460	0	For
Charles Schwab	270,583	0	For
JPMorgan	184,147	0	For
Bridge Builder Trust	143,434	6,045	For
Invesco	148,079	0	For
Brown Capital Management Mutual Funds	145,287	0	For
Principal	137,752	0	For
FINANCIAL INVESTORS TRUST	132,720	0	For
Hartford	110,589	0	For
DRIEHAUS MUTUAL FUNDS	104,954	0	For
Columbia Threadneedle	90,934	0	For
Waddell & Reed	83,243	0	For
Lincoln Financial	81,922	0	For
Equitable	72,895	0	For
QUANTITATIVE MASTER SERIES LLC	55,397	0	For
Jackson National	41,690	0	For
Janus Detroit Street Trust	37,688	0	For
RBB FUND, INC.	36,790	0	For
Empower	31,807	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

7. Elect Director: Merilee Raines

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 21,421,630AGAINST: 224,815

Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: Merilee Raines

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: Merilee Raines”): 21,421,630 for, 224,815 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 12,607,873 for, 38,886 against, 4,796 abstained.

FOR

FOR: 12,607,873AGAINST: 38,886ABSTAIN: 4,796

Largest asset managers voting on “Election of Directors: Merilee Raines” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,478,096	0	For
Fidelity	2,943,949	0	For
BlackRock	1,642,236	0	For
Delaware/Macquarie	768,488	0	For
MUTUAL FUND SERIES TRUST	674,716	0	For
WASATCH FUNDS TRUST	333,215	0	For
Royce	295,460	0	For
Charles Schwab	270,583	0	For
JPMorgan	184,147	0	For
Bridge Builder Trust	149,479	0	For
Invesco	148,079	0	For
Brown Capital Management Mutual Funds	145,287	0	For
Principal	137,752	0	For
FINANCIAL INVESTORS TRUST	132,720	0	For
Hartford	110,589	0	For
DRIEHAUS MUTUAL FUNDS	104,954	0	For
Columbia Threadneedle	90,934	0	For
Waddell & Reed	83,243	0	For
Lincoln Financial	81,922	0	For
Equitable	34,765	38,130	Mixed
QUANTITATIVE MASTER SERIES LLC	55,397	0	For
Jackson National	41,690	0	For
Janus Detroit Street Trust	37,688	0	For
RBB FUND, INC.	36,790	0	For
Empower	31,807	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

8. Elect Director: David Weill, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 21,250,720AGAINST: 395,207

Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: Election of Directors: David Weill, M.D.

TRANSMEDICS GROUP INC.’s own tally for this item (“Elect Director: David Weill, M.D.”): 21,250,720 for, 395,207 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, the shareholders of the Company voted on the following proposals: Proposal One : The shareholders elected Waleed Hassanein, M.D., James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania Jr., Stephanie Lovell, Merilee Raines, and David Weill, M.D. as directors, e…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 12,634,155 for, 12,604 against, 4,796 abstained.

FOR

FOR: 12,634,155AGAINST: 12,604ABSTAIN: 4,796

Largest asset managers voting on “Election of Directors: David Weill, M.D.” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,478,095	1	For
Fidelity	2,943,949	0	For
BlackRock	1,642,236	0	For
Delaware/Macquarie	768,488	0	For
MUTUAL FUND SERIES TRUST	674,716	0	For
WASATCH FUNDS TRUST	333,215	0	For
Royce	295,460	0	For
Charles Schwab	270,583	0	For
JPMorgan	184,147	0	For
Bridge Builder Trust	143,434	6,045	For
Invesco	148,079	0	For
Brown Capital Management Mutual Funds	145,287	0	For
Principal	137,752	0	For
FINANCIAL INVESTORS TRUST	132,720	0	For
Hartford	110,589	0	For
DRIEHAUS MUTUAL FUNDS	104,954	0	For
Columbia Threadneedle	90,934	0	For
Waddell & Reed	83,243	0	For
Lincoln Financial	81,922	0	For
Equitable	72,895	0	For
QUANTITATIVE MASTER SERIES LLC	55,397	0	For
Jackson National	41,690	0	For
Janus Detroit Street Trust	37,688	0	For
RBB FUND, INC.	36,790	0	For
Empower	31,807	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

9. 2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the…

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%

FOR: 20,883,760AGAINST: 755,962

Details: description as filed, official tally, votes by 341 asset managers

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.

TRANSMEDICS GROUP INC.’s own tally for this item (“2. On a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes”): 20,883,760 for, 755,962 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Two : The shareholders approved, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, based on the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 92 asset managers voting on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,476,725	1,371	For
Fidelity	2,943,949	0	For
BlackRock	1,642,236	0	For
Delaware/Macquarie	768,488	0	For
MUTUAL FUND SERIES TRUST	674,716	0	For
WASATCH FUNDS TRUST	333,215	0	For
Royce	295,460	0	For
Charles Schwab	270,583	0	For
JPMorgan	184,147	0	For
Bridge Builder Trust	149,479	0	For
Invesco	0	148,079	Against
Brown Capital Management Mutual Funds	145,287	0	For
Principal	137,752	0	For
FINANCIAL INVESTORS TRUST	132,720	0	For
Hartford	110,589	0	For
DRIEHAUS MUTUAL FUNDS	104,954	0	For
Columbia Threadneedle	90,934	0	For
Waddell & Reed	83,243	0	For
Lincoln Financial	81,922	0	For
Equitable	72,895	0	For
QUANTITATIVE MASTER SERIES LLC	55,397	0	For
Jackson National	29,934	11,756	Mixed
Janus Detroit Street Trust	37,688	0	For
RBB FUND, INC.	36,790	0	For
Empower	31,807	0	For

Fund voting reports, all 92 managers: 12,461,448 for, 185,311 against, 4,796 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 272 asset managers voting on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	4,308,588	0	For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	1,007,665	0	For
BlackRock	661,372	546	For
Liontrust Investment Partners LLP	522,362	0	For
DRIEHAUS CAPITAL MANAGEMENT LLC	500,540	0	For
WASATCH ADVISORS LP	372,959	0	For
State Street	367,721	0	For
JPMorgan	338,720	0	For
BRAIDWELL LP	312,947	0	For
Charles Schwab	303,397	0	For
Hood River Capital Management LLC	290,222	0	For
EMERALD MUTUAL FUND ADVISERS TRUST	262,345	0	For
Northern Trust	254,771	0	For
BROWN CAPITAL MANAGEMENT LLC	219,192	0	For
PRINCIPAL GLOBAL INVESTORS	198,553	0	For
BAILLIE GIFFORD & CO LTD	185,657	0	For
Invesco	0	180,328	Against
Wellington	175,800	0	For
EMERALD ADVISERS, LLC	167,683	0	For
NEW YORK STATE COMMON RETIREMENT FUND	141,838	0	For
MELLON INVESTMENTS Corp	140,345	0	For
Ensign Peak Advisors, Inc	104,848	0	For
First Light Asset Management, LLC	100,893	0	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	100,844	0	For
Lagoda Investment Management, L.P.	97,640	0	For

Institutional-manager reports, all 272 managers: 12,841,511 for, 450,391 against, 7,505 abstained, 19 not voted. Showing the 25 largest; see all in the interactive database.

10. 3. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

92% Approved · of votes cast

FOR 92%

FOR: 24,433,217AGAINST: 2,147,182

Details: description as filed, official tally, votes by 92 asset managers

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.

TRANSMEDICS GROUP INC.’s own tally for this item (“3. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2025, based on the following votes”): 24,433,217 for, 2,147,182 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Three : The shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2025, based on the following votes:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 12,630,712 for, 16,047 against, 4,796 abstained.

FOR

FOR: 12,630,712AGAINST: 16,047ABSTAIN: 4,796

Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered pu” at TRANSMEDICS GROUP INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,476,723	1,373	For
Fidelity	2,943,949	0	For
BlackRock	1,642,236	0	For
Delaware/Macquarie	768,488	0	For
MUTUAL FUND SERIES TRUST	674,716	0	For
WASATCH FUNDS TRUST	333,215	0	For
Royce	295,460	0	For
Charles Schwab	270,583	0	For
JPMorgan	184,147	0	For
Bridge Builder Trust	149,479	0	For
Invesco	148,079	0	For
Brown Capital Management Mutual Funds	145,287	0	For
Principal	137,752	0	For
FINANCIAL INVESTORS TRUST	132,720	0	For
Hartford	110,589	0	For
DRIEHAUS MUTUAL FUNDS	104,954	0	For
Columbia Threadneedle	90,934	0	For
Waddell & Reed	83,243	0	For
Lincoln Financial	81,922	0	For
Equitable	72,895	0	For
QUANTITATIVE MASTER SERIES LLC	55,397	0	For
Jackson National	41,690	0	For
Janus Detroit Street Trust	37,688	0	For
RBB FUND, INC.	36,790	0	For
Empower	31,807	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Not shown here: this season’s fund filings also report 1 item from the meeting of May 23, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest TRANSMEDICS GROUP INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 33,827,880 shares outstanding at the time of that meeting.

Fund voting reports: top TRANSMEDICS GROUP INC. shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	10.28%
2	Fidelity	8.70%
3	BlackRock	4.85%
4	Delaware/Macquarie	2.27%
5	MUTUAL FUND SERIES TRUST	1.99%
6	WASATCH FUNDS TRUST	0.99%
7	Royce	0.87%
8	Charles Schwab	0.80%
9	JPMorgan	0.54%
10	Bridge Builder Trust	0.44%

Institutional-manager reports: top TRANSMEDICS GROUP INC. shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	12.74%
2	MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	2.98%
3	BlackRock	1.96%
4	Liontrust Investment Partners LLP	1.54%
5	DRIEHAUS CAPITAL MANAGEMENT LLC	1.48%
6	WASATCH ADVISORS LP	1.10%
7	State Street	1.09%
8	JPMorgan	1.00%
9	BRAIDWELL LP	0.93%
10	Charles Schwab	0.90%

Reported TRANSMEDICS GROUP INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

TRANSMEDICS GROUP INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	15.51%	13F
FMR (Fidelity)	14.77%	13F
FMR LLC	12.90%	DEF14A
Vanguard Group	10.57%	13F
Vanguard Portfolio Management	5.76%	13G
Waleed H. Hassanein, M.D.	3.89%	DEF14A
State Street	3.86%	13F
Citadel Advisors	3.47%	13F
Morgan Stanley	1.77%	13F
Goldman Sachs	1.50%	13F

Percentages above are of 33,827,880 shares outstanding, as reported by TRANSMEDICS GROUP INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TRANSMEDICS GROUP INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At TRANSMEDICS GROUP INC.'s shareholder meeting held May 22, 2025, in the 2024-2025 proxy season, 343 asset managers reported how they voted on 10 ballot items in their SEC Form N-PX filings, covering 3,314 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named… — TRANSMEDICS GROUP INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: TRANSMEDICS GROUP INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 23, 2025.

TRANSMEDICS GROUP INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.